Brain lesions comprised of aluminum-rich cells that lack microtubules may be associated with the cognitive deficit of Alzheimer's disease

NeuroToxicology

Volumn 30, Issue 6, 2009, Pages 1059-1069

  Walton, J R ^a  

^a Institute for Biomedical Research   (Australia)

Author keywords

Aging; Aluminum; Alzheimer's disease; Animal model; Connectivity; Hippocampus; Immunohistochemistry; Microtubules; Synapses

Indexed keywords

ALUMINUM;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN REGION; COGNITIVE DEFECT; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMBIC CORTEX; MENTAL DETERIORATION; MICROTUBULE; NERVE CELL LESION; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; SYNAPSE;

AGE FACTORS; ALUMINUM; ALUMINUM COMPOUNDS; ALZHEIMER DISEASE; ANIMALS; BRAIN; CHLORIDES; COGNITION DISORDERS; DISCRIMINATION (PSYCHOLOGY); EOSINE I BLUISH; HUMANS; MALE; MAZE LEARNING; MEMBRANE PROTEINS; MICROTUBULES; NERVE TISSUE PROTEINS; NEUROFILAMENT PROTEINS; PYRAMIDAL CELLS; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC; SYNAPSES; TUBULIN;

ANIMALIA; RATTUS; RODENTIA;

EID: 71049182361     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.06.010     Document Type: Article

References (86)

1. Armstrong R.A. Alzheimer's disease: are cellular neurofibrillary tangles linked to β/A4 formation at the projection sites?. Neurosci Res Commun 11 (1992) 171-178
2. Armstrong R.A. Is the clustering of neurofibrillary tangles in Alzheimer's patients related to the cells of origin of specific cortico-cortical projections?. Neurosci Lett 160 (1993) 57-60
3. Armstrong R.A., Anderson J., Cowburn J.D., Cox J., and Blair J.A. Aluminium administered in drinking water but not in the diet influences biopterin metabolism in the rodent. Biol Chem Hoppe-Seyler 373 (1992) 1075-1078
4. Armstrong R.A., and Slaven A. Does the neurodegeneration of Alzheimer's disease spread between visual cortical regions B17 and B18 via the feedforward or feedback short cortico-cortical projections?. Neurodegeneration 3 (1994) 191-196
5. Baas P.W. Microtubule transport in the axon. Int Rev Cytol 212 (2002) 41-62
6. Bannerman D.M., Yee B.K., Good M.A., Heupel M.J., Iversen S.D., and Rawlins J.N.P. Double dissociation of function within the hippocampus. A comparison of dorsal, ventral, and complete hippocampal cytotoxic lesions. Behav Neurosci 113 (1999) 1170-1188
7. Bellows C.G., Heersche J.N., and Aubin J.E. Aluminum accelerates osteoblastic differentiation but is cytotoxic in long-term rat calvaria cell cultures. Calcif Tissue Int 65 (1999) 59-65
8. Bendiske J., Caba E., Brown Q.B., and Bahr B.A. Intracellular deposition, microtubule destabilization, and transport failure: an "early" pathogenic cascade leading to synaptic decline. J Neuropathol Exp Neurol 61 (2002) 640-650
9. Bonhaus D.W., McCormack K.M., Mayor G.H., Mattson J.C., and Hook J.B. The effects of aluminum on microtubular integrity using in vitro and in vivo models. Toxicol Lett 6 (1980) 141-147
10. Braak H., and Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 18 (1997) 351-357
11. Brion J.P., Anderton B.H., Authelet M., Dayanandan R., Leroy K., Lovestone S., et al. Neurofibrillary tangles and tau phosphorylation. Biochem Soc Symp 67 (2001) 81-88
12. Candy J.M., Oakley A.E., Klinowski J., Carpenter T.A., Perry R.H., Atack J.R., et al. Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet i (1986) 354-357
13. Cash A.D., Aliev G., Siedlak S.L., Nunomura A., Fujioka H., Zhu X., et al. Microtubule reduction in Alzheimer's disease and aging is independent of τ filament formation. Am J Pathol 162 (2003) 1623-1627
14. Crapper D.R., and Dalton A.J. Aluminum induced neurofibrillary degeneration, brain electrical activity and alterations in acquisition and retention. Physiol Behav 10 (1973) 935-945
15. Drüeke T.B. Intestinal absorption of aluminium in renal failure. Nephrol Dial Transplant 17 Suppl. 2 (2002) 13-16
16. Edwardson J.A., Candy J.M., Ince P.G., McArthur F.K., Morris C.M., Oakley A.E., et al. Aluminium accumulation, β-amyloid deposition and neurofibrillary changes in the central nervous system. CIBA Found Symp 169 (1992) 165-185
17. Edwardson J.A., Moore P.B., Ferrier I.N., Lilley J.S., Newton G.W.A., Barker J., et al. Effect of silicon on gastrointestinal absorption of aluminium. Lancet 342 (1993) 211-212
18. Einarson L. A method for progressive selective staining of Nissl and nuclear substance in nerve cells. Am J Pathol 8 (1932) 295-308
19. el-Sebae A.K., Abou Zeid M.M., Bdel-Rahman F.H., and Saleh M.A. Binding of aluminum to human serum transferrin, human serum albumin and rat serum proteins. J Environ Sci Health-Part B 29 (1994) 303-321
20. Esiri M.M., and Chance S.A. Vulnerability to Alzheimer's pathology in neocortex: the roles of plasticity and columnar organization. J Alzheimer's Dis 9 (2006) 79-89
21. Flament-Durand J., and Couck A.M. Spongiform alterations in brain biopsies of presenile dementia. Acta Neuropathol 46 (1979) 159-162
22. Flaten T.P. Aluminium as a risk factor in Alzheimer's disease, with emphasis on drinking water. Brain Res Bull 55 (2001) 187-196
23. Gillette-Guyonnet S., Andrieu S., Nourhashemi F., de La Gueronniere V., Grandjean H., and Vellas B. Cognitive impairment and composition of drinking water in women: findings of the EPIDOS Study. Am J Clin Nutr 81 (2005) 897-902
24. Goedert M., Jakes R., Qi Z., Wang J.H., and Cohen P. Protein phosphatase 2A is the major enzyme in brain that dephosphorylates τ protein phosphorylated by proline-directed protein kinases or cyclic AMP-dependent protein kinase. J Neurochem 65 (1995) 2804-2807
25. Gómez-Isla T., Price J.L., McKeel Jr. D.W., Morris J.C., Growdon J.H., and Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci 16 (1996) 4491-4500
26. Gong C.-X., Lidsky T., Wegiel J., Zuck L., and Grundke-Iqbal I. Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem 275 (2000) 5535-5544
27. Gong C.-X., Shaikh S., Wang J.Z., Zaidi T., Grundke-Iqbal I., and Iqbal K. Phosphatase activity toward abnormally phosphorylated τ: decrease in Alzheimer disease brain. J Neurochem 65 (1995) 732-738
28. Gong C.-X., Wegiel J., Lidsky T., Zuck L., Avila J., Wisniewski H.M., et al. Regulation of phosphorylation of neuronal microtubule-associated proteins MAP1b and MAP2 by protein phosphatase-2A and -2B in rat brain. Brain Res 853 (2000) 299-309
29. Good P.F., Perl D.P., Bierer L.M., and Schmeidler J. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 31 (1992) 286-292
30. Gray E.G., Paula-Barbosa M., and Roher A. Alzheimer's disease: paired helical filaments and cytomembranes. Neuropathol Appl Neurobiol 13 (1987) 91-110
31. Greger J.L. Aluminum metabolism. Annu Rev Nutr 13 (1993) 43-63
32. Greger J.L., and Baier M.J. Excretion and retention of low or moderate levels of aluminium by human subjects. Food Chem Toxicol 21 (1983) 473-477
33. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein τ (tau) in cytoskeletal pathology. Proc Natl Acad Sci USA 83 (1986) 4913-4917
34. Hempen B., and Brion J.-P. Reduction of acetylated α-tubulin immunoreactivities in neurofibrillary tangle-bearing neurons in Alzheimer's disease. J Neuropathol Exp Neurol 55 (1996) 964-972
35. Hyman B.T., Van Hoesen G.W., Damasio A.R., and Barnes C.L. Alzheimer's disease: cell-specific pathology isolates the hippocampal formation. Science 225 (1984) 1168-1170
36. Kawahara M., Muramoto Kobayashi K., and Kuroda Y. Functional and morphological changes in cultured neurons of rat cerebral cortex induced by long-term application of aluminum. Biochem Biophys Res Commun 189 (1992) 1317-1322
37. Kosik K.S. Tau protein and neurodegeneration. Mol Neurobiol 4 (1990) 171-179
38. Kowall N.W., Pendlebury W.W., Kessler J.B., Perl D.P., and Beal M.F. Aluminum-induced neurofibrillary degeneration affects a subset of neurons in rabbit cerebral cortex, basal forebrain and upper brainstem. Neuroscience 29 (1989) 329-337
39. Kumar S. Aluminium-induced biphasic effect. Med Hypotheses 52 (1999) 557-559
40. Landsberg J., McDonald B., Grime G., and Watt F. Microanalysis of senile plaques using nuclear microscopy. J Geriatr Psychiatry Neurol 6 (1993) 97-104
41. Landsberg J.P., McDonald B., and Watt F. Absence of aluminium in neuritic plaque cores in Alzheimer's disease. Nature 360 (1992) 65-68
42. Levin E.D., Christopher N.C., and Briggs S.J. Chronic nicotinic agonist and antagonist effects on T-maze alternation. Physiol Behav 61 (1997) 863-866
43. Lieberherr M., Gross B., Cournot-Witner G., Hermann-Erlee M.P., and Balsan S. Kidney Int 31 (1987) 736-743
44. Lindwall G., and Cole R.D. Phosphorylation affects the ability of tau protein to promote microtubule assembly. J Biol Chem 259 (1984) 5301-5305
45. McDermott J.R., Smith A.I., Iqbal K., and Wisniewski H.M. Brain aluminum in aging and Alzheimer disease. Neurology 29 (1979) 809-814
46. MacDonald T.L., Humphreys W.G., and Martin R.B. Promotion of tubulin assembly by aluminum ion in vitro. Science 236 (1987) 183-186
47. Markesbery W.R., Ehmann W.D., Hossain T.I., Alauddin M., and Goodin D.T. Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. Ann Neurol 10 (1981) 511-516
48. Martyn C.N., Barker D.J., Osmond C., Harris E.C., Edwardson J.A., and Lacey R.F. Geographical relation between Alzheimer's disease and aluminum in drinking water. Lancet 1 (1989) 59-62
49. Martyn C.N., Coggon D.N., Inskip H., Lacey R.F., and Young W.F. Aluminum concentrations in drinking water and risk of Alzheimer's disease. Epidemiology 8 (1997) 281-286
50. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41 (1991) 479-486
51. Miu A.C., and Benga O. Aluminum and Alzheimer's disease: a new look. J Alzheimer's Dis 10 (2006) 179-201
52. Moore P.B., Day J.P., Taylor G.A., Ferrier I.N., Fifield L.K., and Edwardson J.A. Absorption of aluminium-26 in Alzheimer's disease, measured using accelerator mass spectrometry. Dement Geriatr Cogn Disord 11 (2000) 66-69
53. Morales M., and Fifková E. Distribution of acetylated α-tubulin in brain: in situ localization and biochemical characterization. Cell Tissue Res 265 (1991) 415-423
54. Morris C.M., Candy J.M., Kerwin J.M., and Edwardson J.A. Transferrin receptors in the normal human hippocampus and in Alzheimer's disease. Neuropathol Appl Neurobiol 20 (1994) 473-477
55. Oshiro S., Kawahara M., Mika S., Muramoto K., Kobayashi K., Ishige R., et al. Aluminum taken up by transferrin-independent iron uptake affects the iron metabolism in rat cortical cells. J Biochem 123 (1998) 42-46
56. Paula-Barbosa M., Tavares M.A., and Cadete-Leite A. A quantitative study of frontal cortex dendritic microtubules in patients with Alzheimer's disease. Brain Res 416 (1987) 139-142
57. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 5th ed. (2005), Elsevier Academic Press, San Diego
58. Pearson R.C.A., Esiri M.M., Hiorns R.W., Wilcock G.K., and Powell T.P. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc Natl Acad Sci USA 82 (1985) 4531-4534
59. Perl D.P., and Brody A.R. Detection of aluminum by SEM-X-ray spectrometry within neurofibrillary tangle-bearing neurons of Alzheimer's disease. Neurotoxicology 1 (1980) 133-137
60. Petit T.L., Biederman G.B., and McMullen P.A. Neurofibrillary degeneration, dendritic dying back, and learning-memory deficits after aluminum administration: implications for brain aging. Exp Neurol 67 (1980) 152-162
61. Petit T.L. The neurobiology of learning and memory: elucidation of the mechanisms of cognitive dysfunction. Neurotoxicology 9 (1988) 413-428
62. Polle E., Konzak C.F., and Kittrick J.A. Visual detection of aluminum tolerance levels in wheat by hematoxylin staining of seedling roots. Crop Sci 18 (1978) 823-827
63. Räihä I., Kaprio J., Koskenvuo M., Rajala T., and Sourander L. Alzheimer's disease in Finnish twins. Lancet 347 (1996) 573-578
64. Reed N.A., Cai D., Blasius T.L., Jih G.T., Meyhofer E., Gaertig J., et al. Microtubule acetylation promotes kinesin-1 binding and transport. Curr Biol 16 (2006) 2166-2172
65. Rogers M.A., and Simon D.G. A preliminary study of dietary aluminium intake and risk of Alzheimer's disease. Age Ageing 28 (1999) 205-209
66. Roskams A.J., and Connor J.R. Aluminum access to the brain: a role for transferrin and its receptor. Proc Natl Acad Sci USA 87 (1990) 9024-9027
67. Schmidt R., Bohm K., Vater W., and Unger E. Aluminium induced osteomalacia and encephalopathy-an aberration of the tubulin assembly into microtubules (MTs) by Al3+?. Prog Histochem Cytochem 23 (1991) 355-364
68. Shimizu H., Mori T., Koama M., Sekiya M., and Ooami H. A correlative study of the aluminum content and aging changes of the brain in non-demented elderly subjects. Nippon Ronen Igakkai Zasshi - Jpn J Geriatr (Tokyo) 31 (1994) 950-960
69. Simchowicz T. Histologische Studien über die senile Demenz. In: Nissl F., and Alzheimer A. (Eds). Histologische und histopathologische Arbeiten über die Grosshirnrinde mit besonderer Berücksichtigung der pathologischen Anatomie der Geisteskranken (1911), Gustav Fischer Verlag, Jena pp. 267-443
70. Sivaguru M., Pike S., Gassmann W., and Baskin T.I. Aluminum rapidly depolymerizes microtubules and depolarises the plasma membrane: evidence that these responses are mediated by a glutamate receptor. Plant Cell Physiol 44 (2003) 667-675
71. Sreekumaran E., Ramakrishna T., Madhav T.R., Anandh D., Prabhu B.M., Sulekha S., et al. Loss of dendritic connectivity in CA1, CA2, and CA3 neurons in hippocampus in rat under aluminum toxicity: antidotal effect of pyridoxine. Brain Res Bull 59 (2003) 421-427
72. Sun Q.B., Shen R.F., Zhao X.Q., Chen R.F., and Dong X.Y. Phosphorus enhances Al resistance in Al-resistant Lespedeza bicolor but not in Al-sensitive L. cuneata under relatively high Al stress. Ann Bot 102 (2008) 795-804
73. Terry R.D., and Wisniewski H.M. Ultra structure of senile dementia and of experimental analysis. In: Gaits C.M. (Ed). Aging and the brain: advances in behavioural biology, vol. 3 (1972), Plenum Press, New York pp. 89, 116
74. Tripathi S., Mahdi A.A., Nawab A., Chander R., Hasan M., Siddiqui M.S., et al. Influence of age on aluminum induced lipid peroxidation and neurolipofuscin in frontal cortex of rat brain: a behavioural, biochemical and ultrastructural study. Brain Res 1253 (2009) 107-116
75. Uemura E., and Ireland W.P. Synaptic density in chronic animals with experimental neurofibrillary changes. Exp Neurol 85 (1984) 1-9
76. Van Hoesen G.W. The parahippocampal gyrus. New observations regarding its cortical connections in the monkey. Trends Neurosci 5 (1982) 345-350
77. Walton J.R. A bright field/fluorescent stain for aluminum: its specificity, validation, and staining characteristics. Biotech Histochem 79 (2004) 169-175
78. Walton J.R. Aluminum in hippocampal neurons from humans with Alzheimer's disease. Neurotoxicology 27 (2006) 385-394
79. Walton J.R. A longitudinal study of rats chronically exposed to aluminum at human dietary levels. Neurosci Lett 412 (2007) 29-33
80. Walton J.R. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration. J Inorg Biochem 101 (2007) 1275-1284
81. Walton J.R. Functional impairment in aged rats chronically exposed to human range dietary aluminum equivalents. Neurotoxicology 30 (2009) 182-193
82. WHO. Aluminium. In: 657. Aluminium (WHO Food Additive Series 24); 1989 [Online]. http://www.inchem.org/documents/jecfa/jecmono/v024je07.htm [Accessed June 22, 2009].
83. Yamamoto H., Saitoh Y., Yasugawa S., and Miyamoto E. Dephosphorylation of tau factor by protein phosphatase 2A in synaptosomal cytosol fractions, and inhibition by aluminum. J Neurochem 55 (1990) 683-690
84. Yokel R.A., and Florence R.L. Aluminum bioavailability from the approved food additive leavening agent acidic sodium aluminum phosphate, incorporated into a baked good, is lower than from water. Toxicology 227 (2006) 86-93
85. Yumoto S., Kakimi S., Ohsaki A., and Ishikawa A. Demonstration of aluminium in the brains of patients with Alzheimer's disease. Eighth Keele Meeting on Aluminum, Trest. Czech Republic, February 21-25 (2009)
86. Zhang Y., Li N., Caron C., Matthias G., Hess D., Khochbin S., et al. HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J 22 (2003) 1168-1179